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Abstract
Characterization of toxicogenomic signatures of carcinogen exposure holds significant promise for mechanistic and
predictive toxicology. In vitro transcriptomic studies allow the comparison of the response to chemicals with diverse mode
of actions under controlled experimental conditions. We conducted an in vitro study in TK6 cells to characterize gene
expression signatures of exposure to 15 genotoxic carcinogens frequently used in European industries. We also examined
the dose-responsive changes in gene expression, and perturbation of biochemical pathways in response to these
carcinogens. TK6 cells were exposed at 3 dose levels for 24 h with and without S9 human metabolic mix. Since S9 had an
impact on gene expression (885 genes), we analyzed the gene expression data from cells cultures incubated with S9 and
without S9 independently. The ribosome pathway was affected by all chemical-dose combinations. However in general, no
similar gene expression was observed among carcinogens. Further, pathways, i.e. cell cycle, DNA repair mechanisms, RNA
degradation, that were common within sets of chemical-dose combination were suggested by clustergram. Linear trends in
dose–response of gene expression were observed for Trichloroethylene, Benz[a]anthracene, Epichlorohydrin, Benzene, and
Hydroquinone. The significantly altered genes were involved in the regulation of (anti-) apoptosis, maintenance of cell
survival, tumor necrosis factor-related pathways and immune response, in agreement with several other studies. Similarly in
S9+ cultures, Benz[a]pyrene, Styrene and Trichloroethylene each modified over 1000 genes at high concentrations. Our
findings expand our understanding of the transcriptomic response to genotoxic carcinogens, revealing the alteration of
diverse sets of genes and pathways involved in cellular homeostasis and cell cycle control.
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Introduction
Cancer is a multifactorial disease in which both environmental
and genetic factors play a role. Thus far, the cancer risk associated
with exposure to industrial pollutants has been mainly assessed
through epidemiological follow-up, animal studies, mutagenicity
and genotoxicity assays. Exposure-related cancers are difficult to
detect in epidemiological studies given that the induced cancer risk
is small compared to the natural occurrence of cancer [1,2,3,4,5]
and latencies can be protracted. Despite the possibility of
measuring genotoxic effects in humans, e.g. DNA breaks and
micronuclei, which can lead to the development of a cancer, the
interpretation of positive findings in relation to exposure and
cancer risk assessment remains a major challenge [6]. With the
development of new tests, it is hoped that more effective bioassay
surrogates will produce clinical tools for monitoring and risk
assessment [7,8,9,10,11].
Collaborative efforts have been taken to deal with the health
effects of large number of chemicals released in the environment
and to develop cost-effective high-throughput approaches to assess
environmental chemical toxicity [12]. In recent years, ‘omic’
technologies have been employed to get a deeper understanding of
toxicological mechanisms and to predict toxicological outcome,
such as carcinogenicity, by profiling genomic perturbations (e.g.,
mRNA expression profile) [13,14,15]. Several promising studies
have been reported in mechanistic [16,17] and predictive
toxicology [18,19,20] using toxicogenomics. Toxicogenomic tools
have also been utilized to discriminate between classes of
carcinogens based on global expression profiling [19,21]. This
suggests that for compounds with insufficient toxicological
information, associated gene signatures could be used to charac-
terize their toxicological properties based on comparison with
signatures associated with previously characterized compounds.
Studies have reported positive findings regarding the toxicoge-
nomic strategy of compound categorization based on the mode of
action (e.g., gene expression alterations) [22] but data is still too
preliminary to support the conclusion that similar gene expression
signatures are observed among families of structurally similar
compound(s) and/or compounds with similar mode of action
[23,24].
Human toxicogenomic studies typically are small, examine high
dose exposures, have confounding issues (such as age, genotype,
and diet) and use various methodologies, all of which make it
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difficult to compare the effects of exposure to different chemicals
or classes of chemicals among studies. In contrast, in vitro
toxicogenomic studies can be designed to examine the effect of
multiple exposures in parallel with greatly reduced confounding. In
vitro gene expression profiling has the potential to discriminate
carcinogens with distinct mechanisms of action [25]. Several in
vitro studies have shown that genotoxic agents alter genes involved
in immune, inflammatory and stress responses and apoptosis,
rather than genes with a role in DNA repair or metabolism, as
might have been expected [26,27,28,29,30,31]. These studies
examined genotoxins that operate through various mechanisms, in
human and mouse cell lines using different microarray platforms.
In the current study, we characterized the gene expression
alterations in TK6 cells induced by by genotoxic carcinogens with
diverse modes of action e.g., adduct forming and cross-linking. We
also examined the dose-responsive changes in gene expression and
altered biochemical pathways. We hypothesized that the gene
expression signatures are perturbed in response to exposure in a
carcinogen, and a dose specific manner. The carcinogens
comprised 13 chemicals currently and frequently used in
European industries, including occupational and environmental
agents, as well as 2 control chemicals (Table 1). These genotoxic
agents react with/alter DNA and/or proteins directly or indirectly
(through their bioactivation) [32].
Human thymidine kinase 6 human lymphoblastoid cells (TK6
cells) were exposed for 24 hours and global gene expression
profiling was performed. In order to assess the applicability of gene
expression profiles to biomonitoring of human populations
exposed to carcinogens, we also examined dose-dependent
changes in gene expression. We applied a long exposure period
(24 h) rather than a pulse treatment (4–6 h), since humans (e.g.
workers) are typically chronically exposed and in in vitro studies, 18
to 24 h exposure period is commonly used for investigation of
genotoxicity [33,34]. Moreover, it has been shown that more
changes in gene expression with alteration of more genes, occurs
after approximately 24 h than after 4, 48, or 72 h
[27,28,29,30,35].
Results
After 24 h of exposure, cells were harvested and analyzed for
viability. All samples included in this study showed viability above
90% and were further processed for RNA extraction. The RNA
from each exposure condition was hybridized to the Sentrix
HumanRef-8 v33 Expression BeadChips (Illumina, Inc., San
Diego, CA).
Assessment of experimental variation
We applied a linear mixed model to assess the proportion of
total variation that is due to exposure (chemical, S9, dose) and
experimental variation (treatment experiment, hybridization, label
and chip). The distribution by gene of the IntraClass Correlation
Coefficients for 3 of the potential experimental confounding
factors (experiment, label, and hybridization) and residual showed
that residual variation was greatest (Figure 1). This means that
exposure, i.e. chemical agent, S9 and dose had the strongest effect
on variation in gene expression. We adjusted the inference for
correlation due to labeling and hybridization, which had lesser
effects on variation than exposure.
Effect of S9 treatment on gene expression
In order to determine the effectiveness of S9 activation in our
treatment experiments, we compared the differential gene
expression profiles of cells treated with Styrene, which requires
metabolic activation, in the presence of S9, with the profiles
associated with its major metabolite, Styrene 7,8-oxide, in the
absence of S9. Styrene and Styrene 7,8-oxide had 297 genes (q-
value,0.15) in common at high dose treatment, and no genes in
common at low and medium doses (Figure 2). The high-dose
result, suggested that S9 affected the metabolism of Styrene to
Table 1. Overview of agents used for the treatment of TK6 cell cultures.
Agents IARC Category Concentration (mM)
High Medium Low
Formaldehyde*,1,2 1 Aldehyde 100 10 1
Styrene**,1 2B Aromatic hydrocarbon 5000 500 50
Styrene 7,8-oxide*,1 2A Aromatic hydrocarbon 500 50 5
Benzene**,1 1 Aromatic hydrocarbon 100 10 1
Hydroquinone*,1 3 Aromatic hydrocarbon 0.5 0.05 0.005
Mitomycin C*,2 2B Cytostaticum 0.5 0.05 0.005
Ethylenedibromide**,1,2 2A Organobromide 1000 100 10
Epichlorohydrin*,1 2A Organochloride 500 50 5
Acrylamide**,1 2A Amide 500 50 5
Trichloroethylene**,1 2A Chlorinated hydrocarbon 5000 500 50
Carbontetrachloride**,1 2B Chlorinated hydrocarbon 1000 100 10
Cyclophosphamide**,1 1 Cytostaticum 50 5 0.5
Benzo[a]fluoranthene**,1 2B Poly aromatic hydrocarbon 500 50 5
Benzo[a]pyrene**,1 1 Poly aromatic hydrocarbon 500 50 5
Benz[a]anthracene**,1 2B Poly aromatic hydrocarbon 500 50 5
*Direct acting agent; **Indirect acting agent,
1: DNA adduct forming agent; 2: DNA Cross linking agent.
doi:10.1371/journal.pone.0039205.t001
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Styrene 7,8-oxide. However, the degree of overlap was small
suggesting that metabolism by S9 was incomplete, or that Styrene
alters gene expression independently of its metabolism or via other
metabolites, or that S9 treatment was causing ‘‘non-target’’ effects
on genes expression. Comparison of the gene expression patterns
of S9-treated (S9+) with S9-untreated (S9-) control samples showed
that 885 genes (supplementary Table S1) were significantly altered
(q-value,0.01), of which 375 genes were down regulated. This
confirmed that ‘‘non-target’’ effects of S9 treatment occurred.
Given these non-target S9 effects on gene expression, we analyzed
the gene expression data from cells cultures incubated without S9
metabolic mix independently from those incubated with S9
metabolic mix.
GO categories and genes significantly impacted by
individual carcinogens vs controls
We examined the genes modulated by each agent at each
concentration. After multiple test correction (False Discovery Rate
(FDR) q-value ,0.15), many exposure-induced gene expression
modifications remained significant. At low-dose exposure, Form-
aldehyde significantly altered the expression of 3 genes (FLJ44653
and SFRS11 were upregulated, CTBP1 was downregulated);
Mitomycin C exposure significantly altered the expression of 21
genes of which 3 were downregulated; and, Acrylamide signifi-
cantly altered the expression of 61 genes. Low-dose exposure to
Benz[a]anthracene, Benzo[a]pyrene, Carbontetrachloride, Cyclo-
phosphamide, Hydroquinone, Trichloroethylene and Styrene also
affected gene expression. At the medium dose level, various
numbers of genes were significantly altered (q-value ,0.15):
Cyclophosphamide (134 genes), Carbontetrachloride (353 genes),
Benz[a]anthracene (397 genes), Trichloroethylene (385 genes),
Epichlorohydrin (826 genes) and Benzene (.1000 genes). Simi-
larly, at the high-dose level, various numbers of genes were
significantly altered (q-value ,0.15): Styrene (7 genes), Acrylamide
(81 genes), Benzene (254 genes), Hydroquinone (332 genes),
Ethylenedibromide (748 genes) and Styrene 7,8-oxide (.1000
genes), Trichloroethylene (.1000 genes), Benz[a]anthracene
(.1000 genes) and Epichlorohydrin (.1000 genes) (q-value
,0.15).
The biological processes impacted by each chemical (S9-) at
each dose level were determined by GO analysis and are
summarized in supplementary Table S2. GO categories which
were affected by at least 4 chemicals per dose level are shown in
Table 2 (low dose), Table 3 (medium dose) and Table 4 (high
Figure 1. Sources of methodological and biological variation within the microarray expression data. Figure represents the distribution
of the intraclass correlation coefficients (the proportion of variability estimated to come from each source on a probe-by-probe basis) calculated by
variance components analysis based on a mixed-effects model allowing assessment of independent contributions of variability from experiment,
label, hybridization, and residual variability. IC: intra-class correlation coefficients; x-axis represent the scale of IC (0–1) and y-axis represent the
frequency of IC.
doi:10.1371/journal.pone.0039205.g001
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dose). A number of GO processes including antigen processing
and presentation of endogenous peptide antigen via MHC class I,
peptide antigen stabilization, DNA damage response, and signal
transduction by p53 class mediator resulting in cell cycle arrest,
were affected at the low dose by most chemicals. Regulation of
translational fidelity, positive regulation of epithelial cell differen-
tiation, antigen processing, and presentation of endogenous
peptide antigen via MHC class I were significantly affected at
the medium and high doses. At the high dose multiple chemicals
were associated with perturbation of regulation of cell redox
homeostasis, cell cycle arrest, inhibition of CREB transcription
factor, and mRNA transcription from RNA polymerase I.
Additional GO processes of interest, impacted at medium and
high levels of exposure, were positive regulation of tumor necrosis
factor receptor, T cell proliferation, selection and costimulation
and negative regulation of type IV hypersensitivity, positive
regulation of DNA repair, nucleotide-excision repair, single strand
break repair, double-strand break repair via homologous recom-
bination, DNA double-strand break processing apoptosis, cell
cycle arrest, programmed cell death and apoptotic nuclear change
(supplementary Table S2). In the supplementary Table S3, we
also provide the GO categories impacted by each chemical (S9+)
at each dose level.
Hierarchical clustering, with heatmap presentation to visualize
the pathways that behave similarly and/or differently within each
chemical-dose combination (S9-), is shown in Figure 3. Signifi-
cantly impacted genes from the respective biological replicates per
chemical were pooled in the hierarchical clustering. Specific
pathways associated with cell cycle alterations, DNA repair i.e.,
mismatch repair, nucleotide excision repair, spliceosome, protea-
Figure 2. Genes in common between Styrene (S9+) and Styrene 7,8-oxide (S9-). Venn diagram indicating the number of genes common
between styrene (S9+) and styrene 7,8-oxide (S9-) at low, medium and high dose (q-value,0.15) exposed TK6 cells. The number of overlapping genes
at each of the dose levels were not significant (q-value,0.15) by Fisher’s exact test.
doi:10.1371/journal.pone.0039205.g002
Table 2. Functional classification of affected genes at low dose.
GO ID GO Processes Carcinogens*
AA BA BP CCL CP FA HQ MMC ST TCE
GO:0009440 Cyanate catabolic process u¨ u¨ O O O O O u¨ u¨ O
GO:0019885 Antigen processing and presentation of
endogenous peptide antigen via MHC class I
u¨ O O u¨ O u¨ u¨ O u¨ u¨
GO:0000085 G2 phase of mitotic cell cycle O u¨ O u¨ u¨ u¨ u¨ u¨ O u¨
GO:0006977 DNA damage response, signal transduction by
p53 class mediator resulting in cell cycle arrest
O u¨ O u¨ u¨ O O O O u¨
GO:0050823 Peptide antigen stabilization O O u¨ u¨ O u¨ u¨ O u¨ u¨
GO:0001833 Inner cell mass cell proliferation O O O O u¨ u¨ u¨ O u¨ O
Functional classification of significantly affected genes by exposure to carcinogens at low dose into Gene Ontology (GO) categories was performed. GO categories that
were affected by 4 or more carcinogens per chemical dose are listed. A list of all GO categories affected per chemical per dose is given in the supplementary Table S2.
*Carcinogens [AA:Acrylamide; BA:Benz[a]anthracene; BP:Benzo[a]pyrene; CCL:Carbontetrachloride; CP:Cyclophosphamide; FA:Formaldehyde; HQ:Hydroquinone;
MMC:Mitomycin C; ST; Styrene; TCE:Trichloroethylene].
doi:10.1371/journal.pone.0039205.t002
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some, ribosome, RNA degradation, and others are enriched within
sets of chemical-dose combinations as shown in Figure 3.
Interestingly, the Ribosome pathway was affected by all chemi-
cal-dose combinations used in this study. In general, we did not
observe pathways that have similar expression among all direct or
indirect- acting carcinogens.
Dose-dependent changes in gene expression induced by
individual carcinogens
Trend analysis of genes impacted by chemicals with S9-
treatment revealed dose-dependent changes in gene expression
for Benzene (20 genes), Hydroquinone (34 genes), Benz[a]anthra-
cene (8 genes), Trichloroethylene (1000 genes) and Epichlorohy-
drin (1000 genes) at q-value ,0.15. We performed GO analysis for
the significantly affected genes and the altered GO categories are
given in supplementary Table S4. Some of the significantly
affected genes (S9-) were involved in DNA repair (e.g.
GO:0033683: nucleotide-excision repair, GO:0006283: transcrip-
tion-coupled nucleotide-excision repair), regulation of cell cycle
(e.g. GO:0000075: cell cycle checkpoint, GO:0007050: cell cycle
arrest), regulation of apoptosis (e.g. GO:0008624: induction of
apoptosis by extracellular signals, GO:0042981: regulation of
apoptosis), regulation of immune response (e.g. GO:0001808
negative regulation of type IV hypersensitivity, GO:0042113: B
cell activation), regulation of translation (e.g. GO:0006412:
translation, GO:0006446: regulation of translational initiation)
and GO:0042535: positive regulation of tumor necrosis factor
biosynthetic process.
A closer look at the genes involved in regulation of tumor
necrosis factors receptors revealed that TNFRSF9 (CD137) and
TNFRSF10B (CD262), both members of the tumor necrosis factor
receptor family, were upregulated with increasing Epichlorohydrin
dose. Interestingly the TNFRSF9 gene was also upregulated at
exposure to high doses of e.g. Styrene 7,8-oxide and Hydroqui-
none. In contrast, TNFRSF10A was downregulated with increas-
ing Epichlorohydrin dose.
Discussion
The current study was set up to detect gene signatures and
biological pathways altered by exposure to occupational and
environmental carcinogens with diverse modes of action (MOA),
using global gene expression analysis. S9 was included for agents
requiring metabolic activation. S9 was found to have an impact on
some of the same pathways as the carcinogens, making it difficult
Table 3. Functional classification of affected genes at medium dose.
GO ID Go Processes Carcinogens*
BA BZ CCL CP EPI TCE
GO:0019885 Antigen processing and presentation of endogenous peptide antigen
via MHC class I
P P O P P P
GO:0001711 Endodermal cell fate commitment P O P O P P
GO:0006450 Regulation of translational fidelity P P P O P P
GO:0030858 Positive regulation of epithelial cell differentiation P O P O P P
Functional classification of significantly affected genes by exposure to carcinogens at medium dose into Gene Ontology (GO) categories was performed. GO categories
that were affected by 4 or more carcinogens per chemical dose are listed. A list of all GO categories affected per chemical per dose is given in the supplementary
Table S2.
*Carcinogens [BA:Benz[a]anthracene; BZ:Benzene; CCL:Carbontetrachloride; CP:Cyclophosphamide; EPI:Epichlorohydrin; TCE:Trichloroethylene].
doi:10.1371/journal.pone.0039205.t003
Table 4. Functional classification of affected genes at high dose.
GO ID GO Processes Carcinogens*
AA BA BZ EDB EPI HQ SO ST TCE
GO:0030503 Regulation of cell redox homeostasis P P O P O O O P O
GO:0042789 mRNA transcription from RNA polymerase I P O P P P P O O O
GO:0007050 Cell cycle arrest P O P O P P O P O
GO:0032792 Inhibition of CREB transcription factor P O O P O P O P O
GO:0043065 Positive regulation of apoptosis P O P O P O O P O
GO:0001975 Response to amphetamine P O P O O P O P O
GO:0001711 Endodermal cell fate commitment O P O O P P O O P
GO:0006450 Regulation of translational fidelity O P O O P P O O P
GO:0015855 Pyrimidine transport O P O O P O P O P
GO:0030858 Positive regulation of epithelial cell differentiation O P O O P P O O P
Functional classification of significantly affected genes by exposure to carcinogens at high dose into Gene Ontology (GO) categories was performed. GO categories that
were affected by 4 or more carcinogens per chemical dose are listed. A list of all GO categories affected per chemical per dose is given in the supplementary Table S2.
*Carcinogens [AA:Acrylamide; BA:Benz[a]anthracene; BZ:Benzene; EDB:Ethylenedibromide; EPI:Epichlorohydrin; HQ:Hydroquinone; SO:Styrene 7,8-oxide; ST:Styrene;
TCE:Trichloroethylene].
doi:10.1371/journal.pone.0039205.t004
Gene Expression Profiles in Human TK6 Cells
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to distinguish carcinogenic-specific effects. As a consequence, gene
expression data of experiments with S9 were considered indepen-
dently and are given in the supplementary files. Our findings
suggest that experimental exposure conditions should be consid-
ered carefully when carrying out all in vitro gene expression
experiments to classify indirect acting carcinogens using S9
metabolic mix.
Comparison with previous in vitro studies of global gene
expression induced by exposure to mutagenic
compounds
Our data confirm the results of Islaih et al. (2005), who found
few robust changes in global gene expression induced by exposure
to mutagenic compounds [36]. In contrast to Hu et al. (2004), who
measured the response to cytostatic agents and found 17 genes
downregulated and 26 genes upregulated in a dose-responsive
manner, no common, robust, dose-responsive gene expression
changes were found for all agents in our study [27]. However, with
increasing concentration, increased numbers of genes were
affected, indicating dose-responsiveness. Further, clear dose-
dependent gene expression changes could be detected for
Benzene, Hydroquinone, Benz[a]anthracene, Trichloroethylene
and Epichlorohydrin. The genes identified by Hu et al. (2004)
encoded products involved in (anti-)apoptosis and in pathways
involved in maintaining cell survival [27]. In our study, some of
the genes that were significantly altered were also involved in the
regulation of (anti-)apoptosis and maintenance of cell survival
(DNA repair, regulation of cell cycle). In addition, genes from
pathways involved in the regulation of immune response and
translation regulation were also altered in our study. These results
are in agreement with studies describing gene alterations in cell
cycle arrest, tumor necrosis factor-related pathways, immune and
stress response and DNA repair after exposure to cigarette smoke,
reactive oxygen species and other genotoxic agents [30,36,37].
Previous studies examining gene expression profiles induced by
genotoxic agents were carried out in several cell types (human
peripheral blood mononuclear cells, HepG2, L5178Y mouse
lymphoma cells, TK6 cells) and show a large variation in the
differential expression level of individual genes
[26,27,30,31,36,37]. The two studies previously carried out in
TK6 cells assessed effects of anti-cancer drugs and showed effects
on the same pathways as in our study [31,36]. Differences in the
expression levels of individual genes between the studies may
partially be explained by different treatment schedules and times
at which gene expression measurements were made. The statistical
approach used in the present study differs from the approaches of
previous studies, in which genes were selected based on fold
expression changes, and could also explain some of the different
outcomes compared to other studies [27,29,31].
In this study we could not find similar pathways among all direct
or indirect- acting carcingoens or pathways, which could
discriminate between direct- and indirect- acting agents. We
found that specific KEGG pathways exhibit similar expression for
certain chemical-dose combinations. The identified KEGG
pathways are mainly involved in cell cycle control, DNA repair
mechanisms, apoptosis, immune response, p53 signaling pathway
and intracellular signaling pathways. Activation of DNA repair
related pathways suggests that carcinogenic exposure elicits a
DNA damage response. Activation of ubiquitin mediated prote-
olysis pathway also suggests the induction of apoptosis [38]. In
general, cellular processes identified by GO analysis and KEGG
pathway analysis were similar. As shown in the heatmap,
upregulation of ribosomal pathways by exposure to many
chemical-dose combinations was significant. This may reflect the
prevention of shutdown of the translational machinery after
carcinogenic exposure and an inherent defense system to restore
the cellular homeostasis through activation of cellular translation.
Effects of individual agents and comparison with
previous studies
We examined the gene expression alterations induced by
individual agents. Altered expression of a set of genes involved
in the regulation of tumor necrosis factor receptors at all levels of
exposure to several agents was striking. The gene product of
TNFRSF9 (CD137), which was upregulated with increasing dose in
our study, enhances immune activity to eliminate tumors.
TNFRSF10B (CD262), which was upregulated, and TNFRSF10A,
which was downregulated, in our study with increasing dose, both
encode receptors that can be activated by tumor necrosis factor-
related apoptosis inducing ligand to transduce an apoptosis signal
and induce cell apoptosis. The effects on tumor necrosis factor-
related target genes and impact on both induction of and
protection from apoptosis was reported previously [36].
Mitomycin C exposure modified the expression of 21 genes of
which 3 were downregulated. The number of genes affected is
within the range of another study [36] examining TK6 cells
exposed to Mitomycin C. In contrast to that study, however, with
mitomycin C exposure we did not find an effect on genes involved
in the upregulation of apoptosis (e.g. MYC). Some of the pathways
e.g., cell cycle, DNA repair affected by the formaldehyde exposure
in our study are in agreement with another in vivo study performed
on rat nasal epithelium exposed to Formaldehyde [39]. GO
categories altered by exposure to Benzene and its metabolites,
mainly Hydroquinone, were also in agreement with previous
studies [40,41]. A study of Carbontertracholoride-induced toxicity
to rat liver demonstrated the induction of cellular damage followed
by the activation of DNA repair genes [14]. Many of the
Carbontetrachloride-induced gene expression alterations profiled
in the current study were also involved in regulating the immune
response, cellular toxicity, DNA damage response and apoptosis.
In general, more genes were affected at high concentrations of
some/several carcinogens, but also the numbers of genes playing a
role in apoptosis and control of cell cycle, specifically.
Relevance to biomarker development
In this study we also looked into the genes and biochemical
pathways that represent potential biomarkers of exposure/effect of
carcinogens in human cells in vitro. The relevance of these genes
and pathways to in vivo biomarkers is uncertain. Peripheral blood
mononuclear cells (PBMC) are easily accessible in human
biomonitoring studies. A similar transcriptomic response in the
PBMC of exposed individuals as in the in vitro studies could suggest
its applicability as a biomarker. Comparing the gene expression
data of Benzene and Hydroquinone in TK6 cells from the present
Figure 3. Heatmap generated by hierarchical clustering of chemical-dose arrays. Heatmap representation of the hierarchical trees of
pathways and differentially expressed genes in each chemicals-dose combination generated using hierarchical clustering with the Euclidean distance
metric and average linkage method. The columns in the Heatmap correspond to each chemical-dose combination and rows correspond to different
KEGG human pathways. Significantly impacted genes from the respective biological replicates per chemical were pooled in the hierarchical
clustering.
doi:10.1371/journal.pone.0039205.g003
Gene Expression Profiles in Human TK6 Cells
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study, with changes in the PBMC transcriptome associated with
occupational benzene exposure, reveals that similar pathways (e.g.
apoptosis, immune response), but not genes, are affected [42,43].
A number of differences potentially underlie the differential effects
on TK6 and human PBMC, such as the fact that TK6 cells are
lymphoblastoid while PBMC comprises a number of different cell
types at various stages of development; the Benzene in our in vitro is
unmetabolized; and, Hydroquinone is only one active metabolite
of Benzene. As well as differences in cell type, in vitro and in vivo
responses to chemical exposure are likely influenced by many
different factors. Comparison of the genes and pathways identified
in the present study with effects induced in vitro in PBMC from
normal human donors should be performed.
Conclusion
In conclusion, we identified perturbed gene expression and
pathways induced in TK6 cells by a group of genotoxic
carcinogens with diverse MOAs, as well as dose-dependent
changes in gene expression and pathways. Many of the pathways
play roles in the survival of the cell. A number of genes
significantly impacted are involved in cell division, e.g., cell cycle
arrest, tumor necrosis related pathways and anti(apoptosis), halt
the cell division until the accumulated mutations, and the DNA
damage is effectively repaired. Future research will involve
confirmation of these effects in human PBMC exposed to these
and additional carcinogens in vitro, to determine their applicability
in human biomonitoring studies. Collaborative efforts similar to
ToxCastTM, Tox21 projects will be required to investigate the in
vitro and in vivo effects of chemicals on a large scale, to develop cost-
effective assays for chemical categorization, for their toxicity
assessment, and to explore chemical toxicity pathways [44].
Materials and Methods
Cell culture
In this in vitro study we assessed gene expression in TK6 cells
exposed to 15 carcinogens. Human TK6 cells were chosen
because they express wild-type p53, grow rapidly in suspension
(population doubling time of 12–14 h), and are frequently
employed in standard genetic toxicology studies [36,45,46]. While
TK6 cells are not necessarily equivalent to the target cells for
carcinogenicity, evidence suggests that they can act as surrogate
target cells [36,47]. TK6 cells, purchased from the European
Collection of Cell Cultures (ECACC, Wiltshire, UK), were
cultured in RPMI 1640 medium containing 10% heat-inactivated
horse serum, 100 U/ml penicillin, 100 mg/ml streptomycin and
2 mM l-glutamine. The cultures were maintained between 105–
106 cells/ml, at 5% CO2 and 37uC. The cells, at a density of
106cells/ml, were divided into 15 treatment groups and 1 control
group and were exposed for 24 h to the carcinogens.
Because most compounds first pass the lung and only after
absorption enter the blood and go through the liver, human liver
S9 mix (1% v/v) was added to parallel cultures within each
treatment and control group [37,48]. Thus for each agent an
experiment (in duplicate) was done with and without S9. Liver S9
fractions were obtained from Celsis (Neuss, Germany) and
contained drug-metabolizing enzymes including the cytochromes
P450, flavinmonooxygenases, and UDP glucuronyltransferases.
An exogenous NADPH-regenerating system (1.3 mM NADP+,
3.3 mM glucose-6-phosphate, 0.4 U/ml glucose-6-phosphate de-
hydrogenase, and 3.3 mM magnesium chloride; BD Biosciences,
Erembodegem, Belgium) required by liver S9 for phase I oxidation
was included in the experiments.
Chemicals, viability assays and selection of concentration
The selected agents have well-described clastogenic, genotoxic
and mutagenic characteristics [49,50]. Agents included in the
current study are capable of forming adducts with DNA either
directly or indirectly through the metabolic formation of reactive
metabolites. Table 1 gives an overview of the agents, classification,
and administered dose. In this project, we focused on carcinogens
used in occupational settings. First, we selected adduct forming
and cross-linking chemicals from International Agency for
Research on Cancers 2007 group 1 (agents carcinogenic to
humans) and 2 (agents probably/possibly carcinogenic to
humans). Secondly, we classified the agents per chemical class
and chose chemicals currently and frequently used in European
industries and hospitals [51]. All compounds were purchased from
Sigma Aldrich and dissolved and diluted in dimethylsulfoxide
(DMSO).
Preliminary viability assays were performed to select three
concentrations per agent, i.e. high concentration (cellular viability
of 90%), medium concentration (1/10 of high concentration) and
low concentration (1/100 of high concentration). We used the 3-
[4,5-dimethylthiazol–2-yl]-2,5-diphenyl tetrazolium bromide
(MTT) viability assay [52] and also counted the proportions of
living and dead cells using a CountessTM Automated Cell Counter
(Invitrogen, Carlsbad, CA).
RNA extraction, labeling, hybridization and quality
control
After 24 h of treatment, cells were immediately processed for
RNA isolation. RNA was extracted using TrizolH Reagent with
the PureLinkTM Micro-to-Midi SystemH according to the
manufacturer’s protocol (Invitrogen, Carlsbad, CA). An on-
column DNase I treatment was carried out during RNA
purification (DNase I, Amplification Grade; Invitrogen, Carlsbad,
CA). The quantity of RNA was measured by NanoDrop
Spectrophotometry and quality (integrity) testing of RNA was
done with an Agilent 2100 bioanalyzer. The RNA 260/280 ratios
of all samples were above 1.84 with an RNA integrity number of at
least 8.5. After isolation, RNA was stored at 280uC until analysis.
The IlluminaH TotalPrepTM-96 RNA Amplification Kit was
used for generating biotinylated, amplified cRNA for hybridiza-
tion following the manufacturer’s directions. The concentration of
cRNA was determined by measuring its absorbance at 260 nm
using a NanoDrop Spectrophotometer and by RiboGreen
fluorescence-based assay (Invitrogen). The size distribution of
cRNA was evaluated by conventional denaturing agarose gel
analysis. Hybridization to the Sentrix HumanRef-8 v33 Expres-
sion BeadChips (Illumina, Inc., San Diego, CA), which contain
.23,000 probes/array targeting genes and known alternative
splice variants from the RefSeq database release, washing and
scanning were performed according to the IlluminaBeadChip
manual (11286340 Rev A). Each BeadChip contained 8 micro-
arrays allowing for the parallel processing of 8 samples for greater
throughput. In order to estimate the technical variation caused by
microarray sample preparation and measurement, we randomized
the experiments at each level i.e., labeling, hybridization reactions
and chips. We used two biological replicates per exposure
condition, six biological replicates for control S9- and four
biological replicates for control S9+ experiments. Quality control
metrics of the microarray raw data including noise, background,
% probe sets present/absent, and 39/59 ratios for internal control
genes were satisfactory and consistent. To allow comparisons, all
chips were scaled to a target intensity of 500 based on all probe sets
on each chip.
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Statistical analysis
Statistical analyses were performed as described in McHale
et al. (2010) [43]. Briefly, we conducted variance components
analysis using a linear mixed model [53] to assess the proportion of
total variation due to variation between subjects, hybridizations,
labels, and chips, both before and after the normalization [quantile
normalization in the affy package [54] in R [55]. For each probe,
we estimated the association between exposure level and
expression level using a mixed-effects model with random
intercepts that accounted for clustering by treatment, hybridiza-
tion, and label. The individual dose-dependent treatment effects
were modeled as fixed effects. We fitted the mixed-effects model in
R with the lmer function in the lme4 package [56]. The
distribution (across all the probes on the microarray) of the
contribution of variance from each of the sources (treatment,
labeling, hybridization and chips) is plotted. We performed
standard differential expression analysis on a probe-by-probe basis
using a modified T-statistic based on the empirical Bayes Limma
(Linear models for microarray data) approach [57,58]. Trend
analysis was performed using Limma where the doses were
numerically coded as 0 (for control), 1 (for the low dose), 2 (for the
medium dose) and 3 (for the high dose). After deriving the raw p-
values on a probe by probe basis, the differentially expressed genes
(probes) were selected via ranking by p-value and using a false
discovery rate cut-off (FDR q-value,0.15) [59].The raw data
discussed here have been deposited in the European Bioinfor-
matics Institute ArrayExpress [60]and is publically accessible
through the accession number E-TABM-1223.
Pathway enrichment
We used a method known as structurally enhanced pathway
enrichment analysis (SEPEA_NT3) [61], which incorporates the
associated network information of KEGG (Kyoto Encyclopedia of
Genes and Genomes) biochemical pathways [62,63,64]. SEPEA
differs from other pathway enrichment methods in that it takes
into account the network structure of the various pathways in the
analyses – pathways where perturbed genes (as a result of
treatment) are closely related to each other in a graph/network
sense are assigned more significance. The gene-wise statistic
chosen to be used by SEPEA_NT3 was the t-statistic correspond-
ing to the treatment effect as reported by the empirical bayes
Limma approach [57]. The null hypothesis tested by SE-
PEA_NT3 states that the distribution of the observed t-statistics
among the probes corresponding to genes in a given pathway is
the same as the distribution among all the probes on the
microarray platform. 104 permutations in the SEPEA_NT3
method were chosen in order to evaluate the significance of
association of the treatment with a particular pathway.
Gene Ontology (GO) analysis
The GO project [65] provides an ontology of defined terms
representing gene product properties in the domains, cellular
components, molecular functions, and biological processes. GO
has a hierarchical structure that forms a directed acyclic graph in
which each term has defined relationships to one or more other
terms in the same domain, which can be described as parent-child
relationships. Every GO term is represented by a node in this
graph, and the nodes are annotated with a set of genes. We used
TopGO (topology-based GO scoring; [66]) to calculate the
significance of biological terms from gene expression data taking
the GO structure into account [67] using the elim algorithm. The
elim score is the p-value returned by Fisher’s exact test, and a node
is marked as significant if the p-value is smaller than a previously
defined threshold [67]. Typically this threshold is set to be 0.01
divided by the number of nodes in the GO graph with at least one
annotated gene. This corresponds to a Bonferroni adjustment of
the p-values. The most highly significant nodes thus derived are
denoted as key nodes.
Generation of heatmap
Average linkage represents the criteria of assigning a new
member (chemical or pathway) to a cluster if the average distance
between the new member and the existing members of the cluster
is small. The heat map of negative log10-transformed p-values
representing the enrichment of the 216 pathways across the
chemical treatments, was generated using hierarchical clustering
with the Euclidean distance metric and average linkage to
generate the hierarchical trees of pathways and chemicals using
the Cluster and Tree view programs [68].
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